The people of the First Light, The Mashpee Wampanoag Tribe, are hoping to put the Bay State's fourth casino in Taunton. The first phase is a tribal welcome center on Stevens Street, the size of a ...

TAUNTON — The Welcome Center located on the acreage governed by the Mashpee Wampanoag Tribe for the future use of First Light Resort & Casino is open to the public. That was the official word ...

The 19-year-old phenom, who is set to finally take over as a starter in the 2025 season, said he has been bullied by his famous uncles, Peyton and Eli, and they have even given him wedgies.

Getty Images Pharmaceutical company Eli Lilly is expected to report fourth-quarter earnings before the bell Thursday. Analysts tracking the company see increased sales and profit for Eli Lilly in ...

Based on the forecasted winter weather, the Town of Mashpee has instituted a parking ban on roads town wide beginning tomorrow, Saturday, February 8 at 6 PM. Notice of the parking ban posted to ...

Mashpee’s Capital Improvement Program Committee approved a request last week to bring the proposed new police station renovations and construction to the May Town Meeting. Town Manager Rodney C ...

Read our editorial standards for more information. Eli Manning prevailed during the FanDuel Kick of Destiny on Sunday. During the Super Bowl 2025 pre-game show on Fox, the former Giants ...

Eli Manning was obviously snubbed by missing out on the Pro Football Hall of Fame class of 2025, but the former New York Giants great is taking it well. In fact, he had a really classy reaction to ...

Many expected Peyton and Eli Manning to achieve that milestone in 2025, but it’s actually Sterling and Shannon who made history," NFL reporter Ari Meirov pointed out. Peyton was inducted into ...

It’s the smallest Hall of Fame class in 20 years. Not making the cut: Eli Manning. The former New York Giants quarterback, a two-time Super Bowl MVP, was bypassed by the 49-member selection ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker came out with a mostly better-than-expected 2025 forecast.